Comparative Efficacy and Safety of Hypnotics for Insomnia in Older Adults: A Systematic Review and Network Meta-Analysis

失眠症 荟萃分析 医学 心理学 精神科 内科学
作者
Hsiao‐Yean Chiu,Hsin‐Chien Lee,Jen‐Wei Liu,Shi-Jun Hua,Pin‐Yuan Chen,Pei‐Shan Tsai,Yu‐Kang Tu
出处
期刊:Social Science Research Network [RELX Group (Netherlands)]
标识
DOI:10.2139/ssrn.3506200
摘要

Background: Hypnotics, such as benzodiazepines and nonbenzodiazepines, have been used to aid sleep and treat insomnia in older adults. However, there is limited information for the comparative efficacy and safety of different hypnotics for insomnia in older adults.Methods: EMBASE, PubMed, ClinicalTrials.gov, and ProQuest Dissertations and Theses A&I databases were searched. We included randomised controlled trials comparing hypnotics with either another hypnotic or placebo for insomnia treatment in elderly people. A multivariate random effect network meta-analysis in a frequentist framework was used for estimations of treatment effects and safety.Findings: Twenty-two articles with 5172 older adults were included. Eszopiclone was ranked as the best therapy for prolonging objective total sleep time (28·60 mins), and low-dose doxepin appeared to be the optimal treatment for increasing subjective total sleep time (28·19 mins) and objective sleep efficiency (6.8%) compared with control. Zaleplon was the most effective therapy in reducing objective and subjective sleep onset latency (-21·63 mins and -15·92 mins) compared with control. The risk of overall adverse events was highest with triazolam use (odd ratio, 1·89, 95% confidence interval 1·10 to 3·25) compared to placebo.Interpretation: Considering unclear risk of bias and the potential adverse effects of benzodiazepines and nonbenzodiazepines, we suggest that low-dose doxepin can be the optimal pharmacotherapy for the improvements of sleep duration and sleep efficiency. Future RCTs investigating the treatment effects of hypnotics, particularly low-dose doxepin, on insomnia in older adults are warranted.Funding Statement: HYC acknowledges the support of the Taiwan Ministry of Science and Technology (MOST 106-2314-B-038 -058 -MY3). YKT was supported by the Ministry of Science and Technology, Taiwan (MOST 106-2314-B-002 -098 -MY3).Declaration of Interests: All authors declared no conflicts of interest in this work.Ethics Approval Statement: The study is registered with PROSPERO, number CRD42016046301.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
飞跃极限发布了新的文献求助10
1秒前
1秒前
李健的应助被科研通管家采纳,获得10
1秒前
英姑的应助被科研通管家采纳,获得10
1秒前
Ava的应助被zenghong采纳,获得10
1秒前
君为臣纲的应助被科研通管家采纳,获得30
1秒前
无花果的应助被科研通管家采纳,获得10
1秒前
共享精神的应助被科研通管家采纳,获得10
1秒前
QDU的应助被科研通管家采纳,获得20
2秒前
跳跃夜白完成签到 ,获得积分10
2秒前
共享精神的应助被科研通管家采纳,获得10
2秒前
潇洒哥完成签到,获得积分10
2秒前
小二郎的应助被科研通管家采纳,获得10
2秒前
April发布了新的文献求助10
2秒前
科研通AI2S的应助被科研通管家采纳,获得10
2秒前
搜集达人的应助被科研通管家采纳,获得10
2秒前
在水一方的应助被科研通管家采纳,获得10
2秒前
君为臣纲的应助被科研通管家采纳,获得10
2秒前
2秒前
Ava的应助被科研通管家采纳,获得10
3秒前
田様的应助被科研通管家采纳,获得10
3秒前
3秒前
科研通AI6.3的应助被Waitcy采纳,获得10
3秒前
所所的应助被科研通管家采纳,获得10
3秒前
3秒前
3秒前
3秒前
活泼沁完成签到 ,获得积分10
4秒前
XX发布了新的文献求助10
4秒前
詩翰发布了新的文献求助10
4秒前
5秒前
大力思雁完成签到,获得积分10
5秒前
柠栀发布了新的文献求助20
5秒前
7秒前
han发布了新的文献求助10
9秒前
10秒前
烟花的应助被cheveux采纳,获得10
10秒前
Anthea完成签到 ,获得积分10
10秒前
桐桐的应助被chenn采纳,获得10
11秒前
小白小王完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194174
求助须知:如何正确求助?哪些是违规求助? 9580103
关于积分的说明 21869209
捐赠科研通 7793764
什么是DOI,文献DOI怎么找? 3437545
关于科研通互助平台的介绍 2560983
邀请新用户注册赠送积分活动 2484291